NT 201 (IncobotulinumtoxinA)

IncobotulinumtoxinA · Merz Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NT 201 (IncobotulinumtoxinA), covering 2021-04-02 to 2021-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines [Phase 3]